Foundation presents grants to six early career cancer researchers
The Mark Foundation for Cancer Research presented grants to six early career scientists who are conducting research projects designed to address unmet needs.
The $4.5 million in funding will come from the foundation’s Emerging Leader Award program, intended to empower these investigators to conductive innovative or risky projects that have the potential to improve outcomes for individuals with cancer.
“One of our top priorities as a foundation is to support the exciting work of the next generation of cancer research leaders,” Michele Cleary, PhD, CEO of the foundation, said in a press release. “We look forward to sustaining long-term partnerships with these exceptional scientists and are very eager for the results of their research to bring substantial benefits to [patients with cancer].”
The recipients and their research project titles are:
- Greg Delgoffe, PhD, of University of Pittsburgh — Improving cancer immunotherapy through metabolic modulation;
- Philip Kranzusch, PhD, of Dana-Farber Cancer Institute — Mechanism of cGAS-STING inactivation in antitumor immunity and disease;
- Amanda Lund, PhD, of New York University — Exploiting lymphatic transport for early detection;
- Mario Suvà, PhD, of Massachusetts General Hospital — Targeting cellular states and plasticity in glioblastoma;
- Jeffrey Tyner, PhD, of Oregon Health & Science University — Drug combinations to preempt resistance in acute myeloid leukemia; and
- Eliezer Van Allen, MD, of Dana-Farber Cancer Institute — Convergence of machine learning and translational genomics for prostate cancer precision medicine.
The Mark Foundation for Cancer Research has awarded more than $15 million to more than 30 early career scientists in the United States since its founding in 2017.